Skip to main content

Treatment Clinical Trials for Prostate Cancer

Review the prostate cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 251-275 of 309

Stereotactic Body Radiation Therapy for the Treatment of Patients with Advanced Prostate Cancer, PRORAD-5 Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Cabozantinib in Combination with Lutetium-177 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, CaboLu Study
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Gamitrinib for the Treatment of Advanced or Refractory Solid Tumors or Lymphoma
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
pTVG-HP DNA Vaccine + Nivolumab + Targeted Radiation Therapy to Resistant Lesions for the Treatment of Biochemically Recurrent, Oligometastatic Prostate Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
CBP-1019 with FOLFOX with or without Bevacizumab, Pembrolizumab, or Enzalutamide for the Treatment of Metastatic Solid Tumors of Epithelial Origin
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
Status: Active
Location: 5 locations
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Cancer Patients
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Tumor Treating Fields Therapy (NovoTTF™-200M and NovoTTF-200A Systems) for the Treatment of Refractory Spinal Metastasis
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Differences in Immunological Effects of Vitamin D Replacement among African American Prostate Cancer Patients with Localized versus Metastatic Disease
Status: Active
Location: 2 locations
Pre-Surgical Tirzepatide-Assisted Weight Loss for the Treatment of Overweight and Obese Men with Diabetes and Prostate Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
4AP for the Treatment of Nerve Injury from Retropubic Prostatectomy in Patients with Localized Prostate Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men with Localized Prostate Cancer on Active Surveillance
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Discontinuation of Standard LHRH Agonist Therapy in Elderly Prostate Cancer Patients
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Cone-Beam Computed Tomography-Based Adaptive Stereotactic Body Radiation Therapy for the Treatment of Intermediate- and Favorable High-Risk Prostate Cancer, DE-CART Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Focal Therapy (Transvesical Single-Port Robotic Partial Prostatectomy versus High-Intensity Focused Ultrasound) for the Treatment of Patients with Prostate Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Focal Ablation with Focal Cryotherapy or High Intensity Frequency Ultrasound for the Treatment of Men with Localized Prostate Cancer
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland